Clinical Trials Directory

Trials / Unknown

UnknownNCT04979273

The Role of Hypertonic Dextrose Spray as Endoscopic Topical Hemostatic Agent for Acute Non-Variceal Upper GI Bleeding

The Role of Hypertonic Dextrose Spray as Endoscopic Topical Hemostatic Agent for Acute Non-Variceal Upper Gastrointestinal Bleeding: A Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
66 (estimated)
Sponsor
Dr Cipto Mangunkusumo General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is conducted to evaluate the effectivity of hypertonic dextrose spray as an endoscopic topical hemostatic agent, compared to conventional agent (adrenaline injection, followed by hemoclip or thermocoagulation), in patients with acute non-variceal upper GI bleeding.

Conditions

Interventions

TypeNameDescription
DRUGDextrose 40 % in Waterinjection of adrenaline 1:20.000, followed by dextrose 40% spray
DRUGAdrenaline 1 Mg/mL Solution for Injectioninjection of adrenaline 1:20.000, followed by thermocoagulation or hemoclip
PROCEDUREargon plasma coagulationThermocoagulation
PROCEDUREHemoclipHemoclip

Timeline

Start date
2021-03-01
Primary completion
2021-12-01
Completion
2021-12-01
First posted
2021-07-28
Last updated
2021-07-28

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT04979273. Inclusion in this directory is not an endorsement.

The Role of Hypertonic Dextrose Spray as Endoscopic Topical Hemostatic Agent for Acute Non-Variceal Upper GI Bleeding (NCT04979273) · Clinical Trials Directory